课题基金 / 基金详情

Endocytic Trafficking Motifs in Syndecan & LDL receptor

Endocytic Trafficking Motifs in Syndecan & LDL receptor
Syndecan 中的内吞转运基序
批准号:
7895223
负责人:
Kevin Jon Williams
金额:
$10.65万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2010-04-30

项目摘要

项目成果

Kevin Jon Williams的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Two classes of molecules - the LDL receptor (LDLr) family and cell-surface heparan sulfate proteoglycans (HSPGs) - are key participants in the transport of hydrophobic nutrients by plasma lipoproteins. We have discovered a novel pathway, in which endocytosis of lipoproteins and other ligands is mediated directly by syndecan HSPGs. Using a chimera, FcR-Synd, that consists of an IgG Fc receptor ectodomain linked to the transmembrane (TM) and cytoplasmic regions of syndecan-1, we found that efficient endocytosis is triggered by clustering of syndecan or the chimera. Clustering causes rapid movement into cholesterol-rich, detergent-insoluble, membrane rafts, and then the actual uptake into the cell requires recruitment of tyrosine kinases and the actin cytoskeleton. Surprisingly, we found that constructs containing either the LDLr TM or the syndecan-1 TM domain localized equally well to rafts upon clustering. Sequence comparisons revealed an unexpected 15- residue consensus between the inner (C-terminal) portions of the syndecan and LDLr TM domains, which was not shared by a protein excluded from rafts. Importantly, this consensus may explain unusual features of the way these two molecules have been shown to process multivalent ligands, such as large apoE-rich remnant lipoproteins. Thus, the central hypothesis of this proposal is that specific motifs of syndecan, including the raft-localizing segment shared with the LDL receptor, direct the sub-cellular trafficking of nutrient-bearing ligands, with specific functional consequences. There are two Aims. Aim 1: Detailed definition of novel trafficking motifs in the LDLr gene family and in syndecan. In Aim 1a, we will use CHO cells andMcArdle hepatocytes to map determinants of raft localization within the TM domain of the LDLr, other members of the LDLr gene family, and syndecan. In Aim 1b, we will map trafficking determinants in the syndecan cytoplasmic tail. In Aim Ic, we will test these determinants in another key cell type, the macrophage, which is of particular interest becauseofits variant endocytic pathway through the LDLr. Aim 2: Functional roles for the novel raft-localizing motif in the LDLr transmembrane domain. In Aim 2a, we will determine the role of TM raft-localizing motifs from Aim 1 in the marked stimulation of ACAT that occurs in macrophages when the LDLr binds multivalent lipoproteins. In Aim 2b, the role of these TM motifs in LDLr-mediated regulation of apoB secretion via re-uptake will be investigated in hepatocytes. These proposed studies will clarify basic mechanisms and functional consequences of these novel endocytic determinants within the LDLr and syndecans, including the role of raft localization during nutrient delivery.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.
双糖链蛋白聚糖缺乏:主动脉瘤形成增加且缺乏动脉粥样硬化保护。
DOI: 10.1016/j.yjmcc.2014.07.014
发表时间: 2014
期刊: Journal of molecular and cellular cardiology
影响因子: 5
作者: [Tang,Tao, Thompson,JoelC, Wilson,PatriciaG, Yoder,MeghanH, Müeller,Julia, Fischer,JensW, Williams,KevinJon, Tannock,LisaR]
通讯作者: Tannock,LisaR
DOI: 10.1186/s12986-015-0011-8
发表时间: 2015
期刊: Nutrition & metabolism
影响因子: 4.5
作者: [Li M, Li C, Liu Y, Chen Y, Wu X, Yu D, Werth VP, Williams KJ, Liu ML]
通讯作者: Liu ML
DOI: 10.1097/med.0b013e32835057e9
发表时间: 2012-04
期刊: Current opinion in endocrinology, diabetes, and obesity
影响因子: --
作者: [Liu ML, Williams KJ]
通讯作者: Williams KJ
DOI: 10.1161/atvbaha.110.209577
发表时间: 2010-09
期刊: Arteriosclerosis, thrombosis, and vascular biology
影响因子: --
作者: [Li M, Yu D, Williams KJ, Liu ML]
通讯作者: Liu ML
Sulfatase-2: Key mediator of atherogenic postprandial dyslipoproteinemia
  • 批准号:
    8613570
  • 项目类别:
  • 资助金额:
    $38.75万
  • 财政年份:
    2013
  • 负责人:
    Kevin Jon Williams
  • 依托单位:
Sulfatase-2: Key mediator of atherogenic postprandial dyslipoproteinemia
  • 批准号:
    8735948
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2013
  • 负责人:
    Kevin Jon Williams
  • 依托单位:
Sulfatase-2: Key mediator of atherogenic postprandial dyslipoproteinemia
  • 批准号:
    9308939
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2013
  • 负责人:
    Kevin Jon Williams
  • 依托单位:
Screens for novel compounds to correct diabetic postprandial dyslipidemia
  • 批准号:
    8129732
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2009
  • 负责人:
    Kevin Jon Williams
  • 依托单位:
海外基金